Epilepsy

SiFor patient information click here Template:DiseaseDisorder infobox

WikiDoc Resources for Epilepsy
Articles
Most recent articles on Epilepsy Most cited articles on Epilepsy Review articles on Epilepsy Articles on Epilepsy in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Epilepsy Images of Epilepsy Photos of Epilepsy Podcasts & MP3s on Epilepsy Videos on Epilepsy
Evidence Based Medicine
Cochrane Collaboration on Epilepsy Bandolier on Epilepsy TRIP on Epilepsy
Clinical Trials
Ongoing Trials on Epilepsy at Clinical Trials.gov Trial results on Epilepsy Clinical Trials on Epilepsy at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Epilepsy NICE Guidance on Epilepsy NHS PRODIGY Guidance FDA on Epilepsy CDC on Epilepsy
Books
Books on Epilepsy
News
Epilepsy in the news Be alerted to news on Epilepsy News trends on Epilepsy
Commentary
Blogs on Epilepsy
Definitions
Definitions of Epilepsy
Patient Resources / Community
Patient resources on Epilepsy Discussion groups on Epilepsy Patient Handouts on Epilepsy Directions to Hospitals Treating Epilepsy Risk calculators and risk factors for Epilepsy
Healthcare Provider Resources
Symptoms of Epilepsy Causes & Risk Factors for Epilepsy Diagnostic studies for Epilepsy Treatment of Epilepsy
Continuing Medical Education (CME)
CME Programs on Epilepsy
International
Epilepsy en Espanol Epilepsy en Francais
Business
Epilepsy in the Marketplace Patents on Epilepsy
Experimental / Informatics
List of terms related to Epilepsy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epilepsy is a common chronic neurological disorder that is characterized by recurrent unprovoked seizures. These seizures are transient signs and/or symptoms due to abnormal, excessive or synchronous neuronal activity in the brain. About 50 million people worldwide have epilepsy at any one time. Epilepsy is usually controlled, but not cured, with medication, although surgery may be considered in difficult cases. Not all epilepsy syndromes are lifelong – some forms are confined to particular stages of childhood. Epilepsy should not be understood as a single disorder, but rather as a group of syndromes with vastly divergent symptoms but all involving episodic abnormal electrical activity in the brain.

Classification

Epilepsies are classified five ways:

1. By their first cause (or etiology).
2. By the observable manifestations of the seizures, known as semiology.
3. By the location in the brain where the seizures originate.
4. As a part of discrete, identifiable medical syndromes.
5. By the event that triggers the seizures, as in primary reading epilepsy.

In 1981, the International League Against Epilepsy (ILAE) proposed a classification scheme for individual seizures that remains in common use. This classification is based on observation (clinical and EEG) rather than the underlying pathophysiology or anatomy and is outlined later on in this article. In 1989, the ILAE proposed a classification scheme for epilepsies and epileptic syndromes. This can be broadly described as a two-axis scheme having the cause on one axis and the extent of localisation within the brain on the other. Since 1997, the ILAE have been working on a new scheme that has five axes: ictal phenomenon, seizure type, syndrome, etiology and impairment.

Diagnosis

The diagnosis of epilepsy requires the presence of recurrent, unprovoked seizures; accordingly, it is usually made based on the medical history. EEG, brain MRI, SPECT, PET, and magnetoencephalography may be useful to discover an etiology for the epilepsy, discover the affected brain region, or classify the epileptic syndrome, but these studies are not useful in making the initial diagnosis.

Long-term video-EEG monitoring for epilepsy is the gold standard for diagnosis, but it is not routinely employed owing to its high cost, low availability and inconvenience.

Convulsive or other seizure-like activity, non-epileptic in origin, can be observed in many other medical conditions. These non-epileptic seizures can be hard to differentiate and may lead to misdiagnosis.

Epilepsy covers conditions with different aetiologies, natural histories and prognoses, each requiring different management strategies. A full medical diagnosis requires a definite categorisation of seizure and syndrome types.

Most common

Brain injury

Brain tumor

Brain hemorrhage

Cerebral palsy

Concussion

Electrolyte disturbances

Encephalitis

Epileptic encephalopathy - Lennox-Gastaut type

Febrile Seizures

Hypoxic encephalopathy

Huntington's Chorea

Hypoglycemia

Idiopathic generalized

Intoxication

Stroke

Uremia

Vitamin deficiency

By organ system

Cardiovascular	Arrythmias, Cardiac failure, Carotid Sinus Syndrome, Hypertensive encephalopathy, Hypotension, Hypovolemia, Orthostatic hypotension, Stokes-Adams Syndrome, Syncope, Valvular heart disease
Chemical / poisoning	Intoxication, Benzene hexachloride, Lead poisoning, Carbonmonoxide poisoning
Dermatologic	Rud Syndrome
Drug Side Effect	4-aminopyridine, acyclovir, alcohol, almotriptan, alprazolam, aminophylline, amitriptyline, amoxapine , amphetamines , amphotericin B, aripiprazole, atomexietine, atorvastatin, azathioprine, baclofen, benztropine , bromocriptine, bupivicaine, bupropion, buspirone, busulfan, cabergoline, caffeine, captopril, carisoprodol, carvedilol, cefepime, cefixime, cefotetan , ceftazidime, cefuroxime, cephalexin, chlorambucil, chloroquine, chlorpromazine, cilastatin/imipenem, ciprofloxacin, cisplatinum, citalopram , clomiphene , clomipramine, clonazepam, clorazepate, clozapine, cocaine, cyclobenzaprine, cyclobenzaprine , cyclophosphamide, cyclosporin, dantrolene , desipramine, dexmethylphenidate, dextroamphetamine, diazepam , dicyclomine, diphenhydramine, donepezil, doripenem, doxepin, doxorubicin, dronabinol, duloxetine, efavirenz, enfluraneketamine, entacapone, epoetin, escitalopram, estazolam, estrogen, eszopiclone, etoposide, fentanyl, fluoxetine, fluphenazine, flurazepam, fluvastatin, ganciclovir, gemifloxacin, ginko biloba, glatiramer, haloperidol, hydroxyzine, imipenim, indomethacin, inteferon beta-1a, inteferon beta-1b, Isoniazid (INH), isotretinoin, ivermectin, ketorolac, levofloxacin, lidocaine, lindane, linezolid, lithium, lomefloxacin , lorazepam, loxapine, mefenamic acid, mefloquin, memantine, meperidine, mephobarbital, meropenem, methocarbamol, methotrexate, methylphenidate, metronidazole, mirazapine, mitoxantrone, modafinil, molindone, montelukast, moxifloxacin, mycophenolate, nalidixic acid, nortriptyline , ofloxacin, olanzapine, ondansetron, oxybutynin, oxycodone, oxymorphone, oxytocin, paroxetine, pentazocine, phenobarbital, phenylpropanolamine, pimozide, pramipexole , prednisone, primidone , procaine , promethazine, propoxyphene , protriptyline, quietapine, rameltron, rasagiline, risperidone, rivastigmine, ropinerole, selegiline, sertraline, sibutramine, sildenafil, sodium oxydate, sumatriptan , tacrine, tacrolimus, tadalafil, temazepam, temozolomide, terbutaline, thalidomide, theophylline, thioridazine, thiothixene, ticlopidine, tinidazole, tizanidine, tolcapone, tolterodine, torsemide, tramadol, tranylcypromine , triazolam, trifluperazine, trihexyphenidyl, valacyclovir, valsartan, vardenafil, venlafaxine, vincristine, zaleplon, zanamivir, ziconotide, zidovudine, ziprasidone, ziprasidone, zolpidem
Ear Nose Throat	Feigenbaum-Bergeron-Richardson syndrome, Wittwer sydnrome, Onychodystrophy -- deafness, Ramsay Hunt Syndrome Type 2, Renier-Gabreels-Jasper syndrome
Endocrine	Hyperglycemia, Hyperthyroidism, Hypoglycemia, Hypoparathyroidism, Hypothyroidism, Mental retardation -- dysmorphism -- hypogonadism -- diabetes complex, X-linked Hypoparathyroidism , DEND syndrome, Feigenbaum-Bergeron-Richardson syndrome
Environmental	Heat stroke
Gastroenterologic	Liver disease -- Retinitis pigmentosa -- polyneuropathy -- epilepsy complex
Genetic	Angelman syndrome, Chromosome 15q triplication syndrome, Chromosome 15q13.3 microdeletion syndrome, Ring Chromosome 20, Chromosome 4, trisomy 4p, Cornelia de Lange syndrome 2, Deafness -- congenital onychodystrophy - recessive form, DEND syndrome, Down's Syndrome, Flynn-Aird syndrome, Lipoid proteinosis of Urbach and Wiethe, X-linked Mental retardation syndromic due to JARID1C mutation, X-linked Wittwer type Mental retardation, Mowat-Wilson syndrome, OFD syndrome type IX, Onychodystrophy -- deafness, Renier-Gabreels-Jasper syndrome, Rud Syndrome, X-linked Spasticity -- mental retardation -- epilepsy, Von Hippel-Lindau Syndrome, X-linked Hypoparathyroidism , X-linked Lissencephaly - 2
Hematologic	No underlying causes
Iatrogenic	No underlying causes
Infectious Disease	Bacteria: Tetany, Meningitis, Brain abscess, Encephalitis, Neurosyphilis Virus: German measles, HIV, Meningitis, Ramsay Hunt Syndrome Type 2, Cytomegalovirus (CMV) Parasites: Toxoplasmosis, Neurocysticercosis, Schistosomiasis, Trypanosomiasis, Cerebral malaria, Paragonimiasis, Ascariasis
Musculoskeletal / Ortho	Craniodiaphyseal dysplasia, Fukuyama type muscular dystrophy, Gurrieri-Sammito-Bellussi syndrome, Epilepsy -- microcephaly -- skeletal dysplasia, Onychodystrophy -- deafness
Neurologic	Alzheimer's Disease, Angelman syndrome, Anophthalmia -- hypyothalamo-pituitary insufficiency, Astrocytoma, Autism, Benign familial infantile epilepsy, Brain abscess, Brain hemorrhage, Brain injury, Brain tumor, Cerebral Palsy, Concussion, Cortical dysplasia -- focal epilepsy syndrome, Creutzfeldt-Jakob Disease, Diomedi-Bernardi-Placidi syndrome, DEND syndrome, Double cortex syndrome, Encephalitis, Familial Encephalopathy with neuroserpin inclusion bodies, Epilepsy -- mental deterioration - Finnish type, Epilepsy -- microcephaly -- skeletal dysplasia, Epileptic encephalopathy - Lennox-Gastaut type, Flynn-Aird syndrome, Familial porencephaly, Focal cortical dysplasia, Huntington's Chorea, Hypoxic encephalopathy, Idiopathic generalized, Intracranial hemorrhage and trauma, Kohlschutter-Tonz syndrome, Liver disease -- retinitis pigmentosa -- polyneuropathy -- epilepsy complex, Meningioma, Microcephaly -- mental retardation -- spasticity -- epilepsy complex, Microcephaly -- pontocerebellar hypoplasia -- dyskinesia complex, Microencephaly, Migraine, Movement disorders, Myoclonic progressive familial epilepsy, Myoclonus progressive epilepsy of Unverricht and Lundborg, Meningitis, Neurocysticercosis, X-linked Hamel type Neurodegenerative syndrome, Neurofibromatosis-1, Neurosyphilis, Perisylvian syndrome, Pick's Disease, Pitt-Hopkins syndrome, Pontocerebellar hypoplasia with infantile spinal muscular atrophy, Presenile dementia, Reye's Syndrome, Renier-Gabreels-Jasper syndrome, Rud Syndrome, Space occupying lesion of the brain, Spastic tetraplegic -- cerebral palsy, Spinocerebellar ataxia 13, Stokes-Adams Syndrome, Stroke, Sturge-Weber Syndrome, Subependymal nodular heterotopia, Transient Ischemic Attack (TIA), Tuberous Sclerosis, X-linked Spasticity -- mental retardation -- epilepsy, X-linked Lissencephaly - 2, Wittwer sydnrome
Nutritional / Metabolic	2-Hydroxyglutaricaciduria, Acute intermittent porphyria, Carbohydrate deficiency glycoprotein syndrome type II, Gaucher's Disease, Type 2 Hydroxyacyl-coa dehydrogenase deficiency, Pellagra, Phenylketonuria, Pyridoxine deficiency
Obstetric/Gynecologic	Childbirth trauma, Eclampsia, Perinatal hypoxia or trauma
Oncologic	Metastasis, Astrocytoma, Meningioma, Von Hippel-Lindau Syndrome
Opthalmologic	Wittwer sydnrome, Anophthalmia -- hypyothalamo-pituitary insufficiency, Liver disease -- retinitis pigmentosa -- polyneuropathy -- epilepsy complex, Rud Syndrome
Overdose / Toxicity	No underlying causes
Psychiatric	Panic attack
Pulmonary	Breath-holding spells (pediatric), Alveolar Hydatid Disease, Hyperventilation, Pediatric Apnea, Pitt-Hopkins syndrome, Hypoxic encephalopathy
Renal / Electrolyte	Alkalosis, Chronic Renal Failure, Hypernatremia, Hypocalcemia, Hypomagnesemia, Hyponatremia, Uremia, Feigenbaum-Bergeron-Richardson syndrome
Rheum / Immune / Allergy	Systemic lupus erythematosus, Polyarteritis nodosa
Sexual	No underlying causes
Trauma	Head trauma
Urologic	No underlying causes
Dental	No underlying causes
Miscellaneous	Alcohol withdrawal, Battaglia Neri syndrome, Degenerative disease, Febrile Seizures, Fryns-Aftimos syndrome, McDowall syndrome, Mental retardation -- epilepsy -- bulbous nose, Mental retardation -- epilepsy, Belgian type Mental retardation syndrome, Nicolaides-Baraitser syndrome, Night terrors, Photosensitive epilepsy, Schaefer-Stein-Oshman syndrome, Sleep disorders, Sleepwalking, Vasovagal syncope

By alphabetical order

2-Hydroxyglutaricaciduria 4-aminopyridine Acute intermittent porphyria acyclovir alcohol Alcohol withdrawal Alkalosis almotriptan alprazolam Alveolar Hydatid Disease Alzheimer's Disease aminophylline amitriptyline amoxapine amphetamines amphotericin B Angelman syndrome Anophthalmia -- hypyothalamo-pituitary insufficiency aripiprazole Arrythmias Ascariasis Astrocytoma atomoxetine atorvastatin Autism azathioprine baclofen Battaglia Neri syndrome Belgian type Mental retardation syndrome, Benign familial infantile epilepsy Benzene hexachloride benztropine Brain abscess Brain hemorrhage Brain injury Brain tumor Breath-holding spells (pediatric) bromocriptine bupivacaine bupropion buspirone busulfan cabergoline caffeine captopril Carbohydrate deficiency glycoprotein syndrome type II Carbonmonoxide poisoning [Cardiac failure]] carisoprodol Carotid Sinus Syndrome carvedilol cefepime cefixime cefotetan ceftazidime cefuroxime cephalexin Cerebral Palsy Childbirth trauma chlorambucil chloroquine chlorpromazine Chromosome 15q triplication syndrome Chromosome 15q13.3 microdeletion syndrome Chromosome 20 ring Chromosome 4, trisomy 4p Chronic Renal Failure cilastatin/imipenem ciprofloxacin cisplatinum citalopram clomiphene clomipramine clonazepam clorazepate clozapine cocaine Concussion Cornelia de Lange syndrome 2 Cortical dysplasia -- focal epilepsy syndrome Craniodiaphyseal dysplasia Creutzfeldt-Jakob Disease cyclobenzaprine cyclophosphamide cyclosporin Cytomegalovirus (CMV) dantrolene Deafness -- congenital onychodystrophy - recessive form Degenerative disease DEND syndrome desipramine dexmethylphenidate dextroamphetamine diazepam dicyclomine Diomedi-Bernardi-Placidi syndrome diphenhydramine donepezil doripenem Double cortex syndrome Down's Syndrome doxepin doxorubicin dronabinol duloxetine Eclampsia efavirenz Embolism Encephalitis enfluraneketamine entacapone Epilepsy -- mental deterioration - Finnish type Epilepsy -- microcephaly -- skeletal dysplasia Epileptic encephalopathy - Lennox-Gastaut type epoetin escitalopram estazolam estrogen eszopiclone etoposide Familial Encephalopathy with neuroserpin inclusion bodies Familial porencephaly Febrile Seizures Feigenbaum-Bergeron-Richardson syndrome fentanyl fluoxetine fluphenazine flurazepam fluvastatin Flynn-Aird syndrome Focal cortical dysplasia Fryns-Aftimos syndrome Fukuyama type muscular dystrophy ganciclovir Gaucher's Disease gemifloxacin German measles Ginko biloba glatiramer Gurrieri-Sammito-Bellussi syndrome haloperidol Head trauma Heat stroke Hepatic failure HIV Huntington's Chorea Type 2 Hydroxyacyl-coa dehydrogenase deficiency hydroxyzine Hyperglycemia Hypernatremia Hypertensive encephalopathy Hyperthyroidism Hyperventilation Hypocalcemia Hypoglycemia Hypomagnesemia Hyponatremia Hypoparathyroidism Hypotension Hypothyroidism Hypovolemia Hypoxic encephalopathy Idiopathic generalized imipenem indomethacin inteferon beta-1a inteferon beta-1b Intoxication Intracranial hemorrhage and trauma Isoniazid (INH) isotretinoin ivermectin Kernicterus ketorolac Kohlschutter-Tonz syndrome Lead poisoning levofloxacin lidocaine lindane linezolid Lipoid proteinosis of Urbach and Wiethe lithium Liver disease -- retinitis pigmentosa -- polyneuropathy -- epilepsy complex lomefloxacin lorazepam loxapine Lupus erythematosus McDowall syndrome mefenamic acid mefloquine memantine Meningioma Meningitis Mental retardation -- dysmorphism -- hypogonadism -- diabetes complex Mental retardation -- epilepsy Mental retardation -- epilepsy -- bulbous nose meperidine mephobarbital meropenem Metastasis methocarbamol methotrexate methylphenidate metronidazole Microcephaly -- mental retardation -- spasticity -- epilepsy complex Microcephaly -- pontocerebellar hypoplasia -- dyskinesia complex Microencephaly Migraine mirtazapine mitoxantrone modafinil molindone montelukast Movement disorders Mowat-Wilson syndrome moxifloxacin mycophenolate Myoclonic progressive familial epilepsy Myoclonus progressive epilepsy of Unverricht and Lundborg nalidixic acid Neurocysticercosis Neurofibromatosis-1 Neurosyphilis Nicolaides-Baraitser syndrome Night terrors nortriptyline OFD syndrome type IX ofloxacin olanzapine ondansetron Onychodystrophy -- deafness Orthostatic hypotension oxybutynin oxycodone oxymorphone oxytocin Panic attack Paragonimiasis paroxetine Pediatric apnea Pellagra pentazocine Perinatal hypoxia or trauma Perisylvian syndrome phenobarbital Phenylketonuria phenylpropanolamine Photosensitive epilepsy Pick's Disease pimozide Pitt-Hopkins syndrome Polyarteritis Nodosa Pontocerebellar hypoplasia with infantile spinal muscular atrophy pramipexole prednisone Presenile dementia primidone procaine promethazine propoxyphene protriptyline Pyridoxine deficiency quietiapine ramelteon Ramsay Hunt Syndrome Type 2 rasagiline Renier-Gabreels-Jasper syndrome Reye's Syndrome risperidone rivastigmine ropinirole Rud Syndrome Schaefer-Stein-Oshman syndrome Schistosomiasis selegiline sertraline sibutramine sildenafil Sleep disorders Sleepwalking sodium oxydate Space occupying lesion of the brain Spastic tetraplegic -- cerebral palsy Spinocerebellar ataxia 13 Stokes-Adams Syndrome Stroke Sturge-Weber Syndrome Subependymal nodular heterotopia sumatriptan Syncope Syphilis tacrine tacrolimus tadalafil temazepam temozolomide terbutaline Tetany thalidomide theophylline thioridazine thiothixene Thrombophlebitis Thrombosis ticlopidine tinidazole tizanidine tolcapone tolterodine torsemide Toxoplasmosis tramadol Transient Ischemic Attack (TIA) tranylcypromine triazolam trifluoperazine trihexyphenidyl Trypanosomiasis Tuberous Sclerosis Uremia valacyclovir valsartan Valvular heart disease vardenafil Vasovagal syncope venlafaxine vincristine Von Hippel-Lindau Syndrome Wittwer sydnrome X-linked Hypoparathyroidism X-linked Lissencephaly - 2 X-linked Mental retardation syndromic due to JARID1C mutation X-linked Spasticity -- mental retardation -- epilepsy X-linked Wittwer type Mental retardation X-linked, Hamel type Neurodegenerative syndrome zaleplon zanamivir ziconotide zidovudine ziprasidone ziprasidone zolpidem Triggers The diagnosis of epilepsy requires that the seizures be unprovoked, with the implication that the provocant is assumed to be something obviously harmful. However, in some epilepsy syndromes, the provocant can reasonably be considered to be part of normal daily life. Examples of these normal provocants include reading, hot water on the head, hyperventilation, and flashing or flickering lights. This last provocant is a special type of reflex epilepsy called photosensitive epilepsy. Although assumed to be a common trigger for epilepsy, among both patients and the public, only around 5% of people with epilepsy are affected by flickering lights. Certain environmental factors can lead to an increased likelihood of seizures in someone with epilepsy or in certain syndromes, for example: being asleep the transition between sleep and wakefulness (hypnogogia) tiredness and sleep deprivation illness constipation menstruation stress or anxiety alcohol consumption. Epidemiology Epilepsy is one of the most common of the serious neurological disorders. Genetic, congenital, and developmental conditions are mostly associated with it among younger patients; tumors are more likely over age 40; head trauma and central nervous system infections may occur at any age. The prevalence of active epilepsy is roughly in the range 5–10 per 1000 people. Up to 50 per 1000 people experience nonfebrile seizures at some point in life; epilepsy's lifetime prevalence is relatively high because most patients either stop having seizures or (less commonly) die. Epilepsy's approximate annual incidence rate is 40–70 per 100,000 in industrialized countries and 100–190 per 100,000 in resource-poor countries; socioeconomically deprived people are at higher risk. In industrialized countries the incidence rate decreased in children but increased among the elderly during the three decades prior to 2003, for reasons not fully understood. Seizure types Main article: Seizure types Seizure types are organized firstly according to whether the source of the seizure within the brain is localized (partial or focal onset seizures) or distributed (generalized seizures). Partial seizures are further divided on the extent to which consciousness is affected. If it is unaffected, then it is a simple partial seizure; otherwise it is a complex partial (psychomotor) seizure. A partial seizure may spread within the brain - a process known as secondary generalization. Generalized seizures are divided according to the effect on the body but all involve loss of consciousness. These include absence (petit mal), myoclonic, clonic, tonic, tonic-clonic (grand mal) and atonic seizures. Seizure syndromes There are many different epilepsy syndromes, each presenting with its own unique combination of seizure type, typical age of onset, EEG findings, treatment, and prognosis. Below are some common seizure syndromes: Infantile spasms (West syndrome) is associated with brain development abnormalities, tuberous sclerosis, and perinatal insults to the brain. It affects infants (as implied by its name), which by definition is between 30 days to 1 year of life. It carries a poor prognosis such that only 5-10% of children with infantile spasms will develop normal to near-normal function, while more than two-thirds will have severe deficits. The typical seizures are characterized by sudden flexor and extensor spasms of head, trunk, and extremities. The key EEG finding in these patients is a hypsarrhythmia, or a high-voltage slow wave with multifocal spikes. The first line treatment for these patients is adrenocorticotropic hormone (ACTH or corticotropin) since traditional antiepileptic drugs generally cannot adequately control seizure activity. Vigabatrin is also used in many countries, and is particularly effective when tuberous sclerosis is the cause of seizures. Generalized 3 Hz spike and wave discharges in EEG Childhood absence epilepsy affects children between the ages of 4 and 12 years of age. These patients have recurrent absence seizures that can occur hundreds of times a day. On EEG, one finds the stereotyped generalized 3 Hz spike and wave discharges. A subset of these patients will also develop generalized tonic-clonic seizures. This condition carries a fairly good prognosis in that these children do not usually show cognitive decline or neurological deficits. First line treatment for pure absence seizures is ethosuximide. If patients do not respond or have mixed seizures along with their absence seizures, then valproic acid can be used. Dravet's syndrome Severe myoclonic epilepsy of infancy (SMEI). This very rare syndrome is delimitated from benign myoclonic epilepsy by its severity and must be differentiated from the Lennox-Gastaut syndrome and Doose’s myoclonic-astatic epilepsy. Onset in first year of life. Symptoms peak at about 5 months of age with febrile hemiclonic or generalized status epilepticus. Boys twice as often affected as girls. Prognosis is poor. In 2005, there were at least around 450 cases reported in the worldwide literature but, now, it is impossible to count the known cases because many probably have been published twice because of the genetic reserach. Most cases are sporadic. Family history of epilepsy and febrile convulsions is present in around 25 percent of the cases, but familial cases are exceptionnal. From: www.dravet.com Benign focal epilepsies of childhood The most common syndromes comprising the benign focal epilepsies of childhood include Benign Childhood Epilepsy with Centro-Temporal Spikes (or benign rolandic epilepsy), and Benign Childhood Epilepsy with Occipital Paroxysms. Benign rolandic epilepsy begins in children between the ages of 3 and 16 years. Apart from their seizure disorder, these patients are otherwise normal. Seizures typically occur at night, and are brief, focal motor events affecting facial and pharyngeal muscles, though may be generalized convulsions as well. Focal seizures may be less frequently reported than more obvious generalized seizures. Between seizures, patients have a stereotyped EEG pattern that includes di- or triphasic sharp waves over the central-midtemporal (Rolandic) regions. Prognosis is quite good overall with seizures disappearing by adolescence. There is no consensus on the first line treatment, however most cases respond well to most anticonvulsants. Juvenile myoclonic epilepsy (JME) begins in patients aged 8 to 20 years. These patients have normal IQ and are otherwise neurologically intact. JME is thought to be genetic, though that is not to say that JME will show in immediate family members. The seizures are morning myoclonic jerks often with generalized tonic-clonic seizures that occur just after waking. 'Petit mal' or absence seizures are less common in cases of JME, but are known to occur more often in young girls. EEG readings reveal generalized spikes with 4-6 Hz spike wave discharges and multiple spike discharges. Interestingly, these patients are often first diagnosed when they have their first generalized tonic-clonic seizure later in life when they experience sleep deprivation (e.g., freshman year in college after staying up late to study for exams). Alcohol is a major contributing factor and those with severe JME should monitor their intake of units. Valproic acid is the first line treatment, whereas carbamazepine can actually worsen symptoms. This condition is lifelong, thus patients must be taught appropriate sleep hygiene to prevent generalized tonic-clonic seizures. The severity of JME varies from person to person - some will experience full blown tonic-clonic seizures regularly, others will suffer only under sufficient stress from lack of sleep and intoxication. Temporal lobe epilepsy is the most common epilepsy of adults. In most cases, the epileptogenic region is found in the mesial temporal structures (e.g., the hippocampus, amygdala, and parahippocampal gyrus). Seizures begin in late childhood and adolescence. There is an association with febrile seizures in childhood, and some studies have shown herpes simplex virus (HSV) DNA in these regions, suggesting that perhaps this epilepsy has an infectious etiology. Most of these patients have complex partial seizures sometimes preceded by an aura, and some TLE patients also suffer from secondary generalised tonic-clonic seizures. If the patient does not respond sufficiently to medical treatment, surgery may be considered. Fetal alcohol syndrome (FAS) is caused by prenatal alcohol exposure and results in central nervous system (CNS) damage. Seizure disorders due to prenatal alcohol exposure are one of several possible criteria for diagnosing FASD; however, any seizure disorder due to postnatal insult does not qualify as a diagnostic criterion for FASD. Frontal lobe epilepsy Lennox-Gastaut syndrome Occipital lobe epilepsy Treatment Epilepsy is usually treated with medication prescribed by a physician; primary caregivers, neurologists, and neurosurgeons all frequently care for people with epilepsy. In some cases the implantation of a stimulator of the vagus nerve, or a special diet can be helpful. Neurosurgical operations for epilepsy can be palliative, reducing the frequency or severity of seizures; or, in some patients, an operation can be curative. Responding to a seizure In most cases, the proper emergency response to a generalized tonic-clonic epileptic seizure is simply to prevent the patient from self-injury by moving him or her away from sharp edges, placing something soft beneath the head, and carefully rolling the person into the recovery position to avoid asphyxiation. In some cases the person may seem to start snoring loudly following a seizure, before coming to. This merely indicates that the person is beginning to breathe properly and does not mean he or she is suffocating. Should the person regurgitate, the material should be allowed to drip out the side of the person's mouth by itself. If a seizure lasts longer than 5 minutes, or if the seizures begin coming in 'waves' one after the other - then Emergency Medical Services should be contacted immediately. Prolonged seizures may develop into status epilepticus, a dangerous condition requiring hospitalization and emergency treatment. Objects should never be placed in a person's mouth by anybody - including paramedics - during a seizure as this could result in serious injury to either party. Despite common folklore, it is not possible for a person to swallow their own tongue during a seizure. However, it is possible that the person will bite their own tongue, especially if an object is placed in the mouth. With other types of seizures such as simple partial seizures and complex partial seizures where the person is not convulsing but may be hallucinating, disoriented, distressed, or unconscious, the person should be reassured, gently guided away from danger, and sometimes it may be necessary to protect the person from self-injury, but physical force should be used only as a last resort as this could distress the person even more. In complex partial seizures where the person is unconscious, attempts to rouse the person should not be made as the seizure must take its full course. After a seizure, the person may pass into a deep sleep or otherwise they will be disoriented and often unaware that they have just had a seizure, as amnesia is common with complex partial seizures. The person should remain observed until they have completely recovered, as with a tonic-clonic seizure. After a seizure, it is typical for a person to be exhausted and confused. Often the person is not immediately aware that they have just had a seizure. During this time one should stay with the person - reassuring and comforting them - until they appear to act as they normally would. Seldom during a seizure the person may have soiled themselves. In some instances the person may also vomit after coming to. People should not eat or drink until they have returned to their normal level of awareness, and they should not be allowed to wander about unsupervised. Many patients will sleep deeply for a few hours after a seizure - this is common for those having just experienced a more violent type of seizure such as a tonic-clonic. In about 50% of people with epilepsy, headaches may occur after a seizure. These headaches share many features with migraines, and respond to the same medications. It is helpful if those present at the time of a seizure make note of how long and how severe the seizure was. It is also helpful to note any mannerisms displayed during the seizure. For example, the individual may twist the body to the right or left, may blink, might mumble nonsense words, or might pull at clothing. Any observed behaviors, when relayed to a neurologist, may be of help in diagnosing the type of seizure which occurred. Pharmacologic treatment Main article: Anticonvulsant Some medications can be taken daily in order to prevent seizures altogether or reduce the frequency of their occurrence. These are termed "anticonvulsant" or "antiepileptic" drugs (sometimes AEDs). All such drugs have side effects that are idiosyncratic and others that are dosage-dependent. It is not possible to predict who will suffer from side effects or at what dose the side effects will appear. Some people with epilepsy will experience a complete remission when treated with an anticonvulsant medication. If this does not occur, the dose of medication may be increased, or another medication may be added to the first. The general strategy is to increase the medication dose until either the seizures are controlled, or until dose-limiting side effects appear; at which point the medication dose is reduced to the highest amount that did not produce undesirable side effects. Serum levels of AEDs can be checked to determine medication compliance and to assess the effects of drug-drug interactions; some physicians do not use serum levels to fine tune medication, but other physicians believe that serum levels provide excellent data for tailoring medications to suit an individual's specific and relatively variable body chemistry. For example, therapeutic doses (the dose at which seizures are controlled and side effects are minimal and tolerable) may vary widely from among patients. The therapeutic ranges provided by pharmaceutical companies are only ranges and by using blood serum levels and seizures diaries, better seizure control can sometimes be reached. In some cases (such as a seizure flurry) serum levels can be useful to know if the level is very high or very low. If a person's epilepsy cannot be brought under control after adequate trials of two or three (experts vary here) different drugs, that person's epilepsy is generally said to be medically refractory. or Drug-Resistant Epilepsy. Ketogenic diet (a high-fat, low-protein, low-carbohydrate diet) is used in children with drug-resistant epilepsy. A randomized, controlled trial showed that the number of seizures fell by more than 50% in approximately half of children after 1 year on the diet. Various drugs may prevent seizures or reduce seizure frequency: these include carbamazepine (common brand name Tegretol), clobazam (Frisium), clonazepam (Klonopin), ethosuximide (Zarontin), felbamate (Felbatol), fosphenytoin (Cerebyx), flurazepam (Dalmane), gabapentin (Neurontin), lamotrigine (Lamictal), levetiracetam (Keppra), oxcarbazepine (Trileptal), mephenytoin (Mesantoin), phenobarbital (Luminal), phenytoin (Dilantin), pregabalin (Lyrica), primidone (Mysoline), sodium valproate (Epilim), tiagabine (Gabitril), topiramate (Topamax), valproate semisodium (Depakote, Epival), valproic acid (Depakene, Convulex), vigabatrin (Sabril), and zonisamide (Zonegran). Other drugs are commonly used to abort an active seizure or interrupt a seizure flurry; these include diazepam (Valium) and lorazepam (Ativan). Drugs used only in the treatment of refractory status epilepticus include paraldehyde (Paral) and pentobarbital (Nembutal). Bromides were the first of the effective anticonvulsant pure compounds, but are no longer used in humans due to their toxicity and low efficacy. It has been found that taking valproates while pregnant can have high chances of reduced IQ towards children. Surgical treatment Surgical treatment can be an option for epilepsy when an underlying brain abnormality, such as a benign tumor or an area of scar tissue (e.g. hippocampal sclerosis) can be identified. The abnormality must be removable by a neurosurgeon. Surgery is usually only offered to patients when their epilepsy has not been controlled by adequate attempts with multiple medications. Before surgery is offered, the medical team conducts many tests to assess whether removal of brain tissue will result in unacceptable problems with memory, vision, language or movement, which are controlled by different parts of the brain. These tests usually include a neuropsychological evaluation, which sometimes includes an intracarotid sodium amobarbital test (Wada test) - although this invasive procedure is being replaced by non-invasive functional MRI in many centres. Resective surgery, as opposed to palliative, successfully eliminates or significantly reduces seizures in about 50-90% of the patients who undergo it (the exact percentage depends on the particulars of the case and surgeon in question.) Many patients decide not to undergo surgery owing to fear or the uncertainty of having a brain operation. The most common form of resective surgical treatment for epilepsy is to remove the front part of either the right or left temporal lobe. A study of 48 patients who underwent this operation, anterior temporal lobectomy, between 1965 and 1974 determined the long-term success of the procedure. Of the 48 patients, 21 had had no seizures that caused loss of consciousness since the operation. Three others had been free of seizures for at least 19 years. The rest had either never been completely free of seizures or had died between the time of the surgery and commencement of the study. Palliative surgery for epilepsy is intended to reduce the frequency or severity of seizures. Examples are callosotomy or commissurotomy to prevent seizures from generalizing (spreading to involve the entire brain), which results in a loss of consciousness. This procedure can therefore prevent injury due to the person falling to the ground after losing consciousness. It is performed only when the seizures cannot be controlled by other means. Resective surgery can be considered palliative if it is undertaken with the expectation that it will reduce but not eliminate seizures. Hemispherectomy is a drastic operation in which most or all of one half of the cerebral cortex is removed. It is reserved for people suffering from the most catastrophic epilepsies, such as those due to Rasmussen syndrome. If the surgery is performed on very young patients (2-5 years old), the remaining hemisphere may acquire some rudimentary motor control of the ipsilateral body; in older patients, paralysis results on the side of the body opposite to the part of the brain that was removed. Because of these and other side effects it is usually reserved for patients who have exhausted other treatment options. Other treatment Ketogenic diets may occasionally be effective in controlling some types of epilepsy; although the mechanism behind the effect is not fully understood, shifting of pH towards a metabolic acidosis and alteration of brain metabolism may be involved. Ketogenic diets are high in fat and extremely low in carbohydrates, with intake of fluids often limited. This treatment, originated as early as the 1920s at Johns Hopkins Medical Center, was largely abandoned with the discovery of modern anti-epileptic drugs, but recently has returned to the anti-epileptic treatment arsenal. Ketogenic diets are sometimes prescribed in severe cases where drugs have proven ineffective. A study conducted by Johns Hopkins reported that 50% of those patients starting the Ketogenic diet reported a decrease in seizures of 50% or more, with 29% of patients reporting a 90% reduction in symptoms; these patients had previously tried an average of six anticonvulsant drugs. Vagus nerve stimulation (VNS) is a recently developed form of seizure control which uses an implanted electrical device, similar in size, shape and implant location to a heart pacemaker, which connects to the vagus nerve in the neck. Once in place the device can be set to emit electronic pulses, stimulating the vagus nerve at pre-set intervals and milliamp levels. Treatment studies have shown that approximately 50% of those treated in this fashion will show significant seizure reduction. The Responsive Neurostimulator System (RNS) is currently undergoing clinical study prior to FDA approval. This system relies upon a device implanted just under the scalp. The leads attached to the device are implanted either on the brain surface or in the brain area itself and are located close to the area where the seizures are believed to start. When a seizure begins, an electrical shock is delivered to suppress it. This system is different from the VNS system in that the RNS relies on direct brain stimulation and the RNS is a responsive system. The VNS pulses at predetermined intervals previously set by medical personnel. The RNS system responds to detected signs that a seizure is about to begin and can record events and allow customized response patterns which may provide a greater degree of seizure control. A seizure response dog is a form of service dog that is trained to summon help or ensure personal safety when a seizure occurs. These are not suitable for everybody and not all dogs can be so trained. Rarely, a dog may develop the ability to sense a seizure before it occurs. A number of systematic reviews by the Cochrane Collaboration into treatments for epilepsy looked at acupuncture, psychological interventions, vitamins and yoga and found there is no reliable evidence to support the use of these as treatments for epilepsy. Further studies are needed on the subject. Electrophysiology Most epileptics seize without warning, and their seizures can have dangerous or fatal consequences, if they come at a bad time and lead to an accident. In the brain, identifiable electrical changes precede the clinical onset of a seizure by tens of seconds, and these changes can be recorded in an electroencephalogram (EEG). Many people have wondered if EEG’s might be used to predict seizures minutes or even hours ahead of time, but as of now, this sort of prediction has not been feasible. Many researchers are working, however, to create a system capable of detecting seizures before they clinically manifest themselves. The early detection of a seizure has many potential benefits. Advanced warning would allow patients to take action to minimize their risk of injury and, in some circumstances, would allow them to summon help. An automatic detection system could also be made to trigger pharmacological intervention in the form of fast-acting drugs or electrical stimulation. It is relatively easy to place the electrodes needed to record an EEG, but it has not been so easy to develop an algorithm to detect the onset of a seizure. For any given patient, assuming his or her seizures originate in one focus, seizure-onset EEG patterns are largely conserved from one seizure episode to the next. Unfortunately, there is great EEG variation between patients, both in terms of baseline and in terms of seizure-onset patterns. This variation has made the development of a generic, “one-size-fits-all” algorithm difficult. Patient-specific algorithms based on machine learning have shown more promise. Machine learning algorithms compute binary decision trees from manually labeled training sets of data. EEG data must be translated into a format that the computer can interpret. Important information must be kept while superfluous information must be discarded. Although there are many conceivable ways of performing this “feature extraction,” wavelet decomposition seems to be an effective way of extracting pertinent information from EEG signals. The training set for the machine-learning algorithm must be labeled by hand. For an algorithm being developed by Dr. Schachter and Prof. Guttag of MIT, EEG recordings are split into two-second time windows, and each window is labeled as “seizure onset” or “not seizure onset.” The algorithm then takes the labeled training set and uses it to construct a decision tree capable of classifying unlabeled EEG patterns as “seizure onset” or “not seizure onset.” The training set is unavoidably unbalanced because most time windows do not involve seizures. Certain algorithms, such as the support vector machine algorithm chosen by Schachter and Guttag, are better suited than others to handle this unbalanced training set. In the hospital, the patient-specific algorithm of Schachter and Guttag has worked fairly well. In one trial, it detected 131 out of 139 seizures in 36 patients. In another, it caught 53 out of 58 seizures. The algorithm outperformed generic algorithms. In the future, Dr. Schachter and Prof. Guttag hope to improve their algorithm so that it is less sensitive to electrode placement and so that it functions effectively with input from fewer electrodes and with smaller training sets. Their goal is to create an unobtrusive device that can be worn continually by epileptics to detect impending seizures. Such a device would greatly enhance the ability of these people to safely go about their lives. Pathophysiology Mutations in several genes have been linked to some types of epilepsy. Several genes that code for protein subunits of voltage-gated and ligand-gated ion channels have been associated with forms of generalized epilepsy and infantile seizure syndromes. Several ligand-gated ion channels have been linked to some types of frontal and generalized epilepsies. Epilepsy-related mutations in some non-ion channel genes have also been identified. One interesting finding in animals is that repeated low-level electrical stimulation to some brain sites can lead to permanent increases in seizure susceptibility: in other words, a permanent decrease in seizure "threshold." This phenomenon, known as kindling (by analogy with the use of burning twigs to start a larger fire) was discovered by Dr. Graham Goddard in 1967. Chemical stimulation can also induce seizures; repeated exposures to some pesticides have been shown to induce seizures in both humans and animals. One mechanism proposed for this is called excitotoxicity. The roles of kindling and excitotoxicity, if any, in human epilepsy are currently hotly debated. Other causes of epilepsy are brain lesions, where there is scar tissue or another abnormal mass of tissue in an area of the brain. History and stigma The word epilepsy is derived from the Greek epilepsia, which in turn can be broken in to epi- (upon) and lepsis (to take hold of, or seizure) In the past, epilepsy was associated with religious experiences and even demonic possession. In ancient times, epilepsy was known as the "Sacred Disease" because people thought that epileptic seizures were a form of attack by demons, or that the visions experienced by persons with epilepsy were sent by the gods. Among animist Hmong families, for example, epilepsy was understood as an attack by an evil spirit, but the affected person could become revered as a shaman through these otherworldly experiences.[2] However, in most cultures, persons with epilepsy have been stigmatized, shunned, or even imprisoned; in the Salpêtrière, the birthplace of modern neurology, Jean-Martin Charcot found people with epilepsy side-by-side with the mentally retarded, those with chronic syphilis, and the criminally insane. In Tanzania to this day, as with other parts of Africa, epilepsy is associated with possession by evil spirits, witchcraft, or poisoning and is believed by many to be contagious. In ancient Rome, epilepsy was known as the Morbus Comitialis ('disease of the assembly hall') and was seen as a curse from the gods. Stigma continues to this day, in both the public and private spheres, but polls suggest it is generally decreasing with time, at least in the developed world; Hippocrates remarked that epilepsy would cease to be considered divine the day it was understood. Notable people with epilepsy Main article: List of people with epilepsy Many notable people, past and present, have carried the diagnosis of epilepsy. In many cases, their epilepsy is a footnote to their accomplishments; for some, it played an integral role in their fame. Historical diagnoses of epilepsy are not always certain; there is controversy about what is considered an acceptable amount of evidence in support of such a diagnosis. Legal implications Most people diagnosed with epilepsy are forbidden by their local laws from operating vehicles. However, there are usually exceptions for those who can prove that they have stabilized their condition. Those few whose seizures do not cause impairment of consciousness, or whose seizures only arise from sleep, may be exempt from such restrictions, depending on local laws. There is an ongoing debate in bioethics over who should bear the burden of ensuring that an epilepsy patient does not drive a car or fly an airplane. In the U.S., people with epilepsy can drive if their seizures are controlled with treatment and they meet the licensing requirements in their state. How long they have to be free of seizures varies in different states, but it is most likely to be between three months and a year. The majority of the 50 states place the burden on patients to report their condition to appropriate licensing authorities so that their privileges can be revoked where appropriate. A minority of states (including California) place the burden of reporting on the patient's physician. After reporting is carried out, it is usually the driver's licensing agency that decides to revoke or restrict a driver's license. In the UK, it is the responsibility of the patients to inform the Driver and Vehicle Licensing Agency (DVLA) if they have epilepsy. The DVLA rules are quite complex, but in summary, those continuing to have seizures or who are within 6 months of medication change may have their licence revoked. A doctor who becomes aware that a patient with uncontrolled epilepsy is continuing to drive has, after reminding the patient of their responsibility, a duty to break confidentiality and inform the DVLA. The doctor should advise the patient of the disclosure and the reasons why their failure to notify the agency obliged the doctor to act. Important investigators of epilepsy Jean-Martin Charcot John Hughlings Jackson Hans Berger Herbert Jasper Wilder Penfield H. Houston Merritt William G. Lennox See also Seizure Non-epileptic seizures Epilepsy in animals Seizure response dog Jacksonian seizure Photosensitive epilepsy Temporal lobe epilepsy Abdominal epilepsy Generalised epilepsy ISAS (Ictal-Interictal SPECT Analysis by SPM) Notes and references External Links Patient Resources Epilepsy information and advice from Epilepsy Action. Epilepsy Information Page from the National Institute of Neurological Disorders and Stroke. Health Topics: Epilepsy from MedlinePlus. Epilepsy.com from the Epilepsy Therapy Development Project. Information on epilepsy from the National Society for Epilepsy. Answerplace from the Epilepsy Foundation. Professional resources International League Against Epilepsy. e-epilepsy from the National Society for Epilepsy. Seizures and Epilepsy from eMedicine. Epilepsy Currents from PubMed Central Lists of organizations Many organisations provide regional support for those with epilepsy, their families and professionals in the field. Lists of such groups can be found at: Epilepsy.com: Epilepsy Websites. International Bureau for Epilepsy (IBE) An umbrella group for various national and regional epilepsy support organisations. For local groups, see their list of chapters and friends. The International League Against Epilepsy (ILAE). A list of professional organisations at ILAE: Links. The Joint Epilepsy Council of the UK and Ireland - The JEC is an umbrella organisation which exists to represent the united voice of a number of UK and Irish based epilepsy charities. Template:Diseases of the nervous system Template:SIB Template:Link FA Template:WikiDoc Sources